Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the Steroids for Corneal Ulcers Trial show elevated resistance to fluoroquinolones
- PMID: 24761794
- PMCID: PMC4008435
- DOI: 10.1186/1471-2415-14-54
Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the Steroids for Corneal Ulcers Trial show elevated resistance to fluoroquinolones
Abstract
Background: To determine the relationship between type three secretion genotype and fluoroquinolone resistance for P. aeruginosa strains isolated from microbial keratitis during the Steroids for Corneal Ulcers Trial (SCUT) and for two laboratory strains, PA103 and PAO1.
Methods: Confirmed P. aeruginosa isolates from the SCUT were divided into exoU(+) or exoU(-). The exoU(+) strains contained the gene encoding ExoU, a powerful phospholipase toxin delivered into host cells by the type three secretion system. Isolates were then assessed for susceptibility to fluoroquinolone, cephalosporin, and aminoglycoside antibiotics using disk diffusion assays. Etest was used to determine the MIC of moxifloxacin and other fluoroquinolones. Laboratory isolates in which the exoU gene was added or deleted were also tested.
Results: A significantly higher proportion of exoU(+) strains were resistant to ciprofloxacin (p = 0.001), gatifloxacin (p = 0.003), and ofloxacin (p = 0.002) compared to exoU(-) isolates. There was no significant difference between exoU(+) or exoU(-) negative isolates with respect to susceptibility to other antibiotics except gentamicin. Infections involving resistant exoU(+) strains trended towards worse clinical outcome. Deletion or acquisition of exoU in laboratory isolates did not affect fluoroquinolone susceptibility.
Conclusions: Fluoroquinolone susceptibility of P. aeruginosa isolated from the SCUT is consistent with previous studies showing elevated resistance involving exoU encoding (cytotoxic) strains, and suggest worse clinical outcome from infections involving resistant isolates. Determination of exoU expression in clinical isolates of P. aeruginosa may be helpful in directing clinical management of patients with microbial keratitis.
Figures

Similar articles
-
Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India.Ophthalmic Epidemiol. 2013 Jun;20(3):155-8. doi: 10.3109/09286586.2013.790978. Epub 2013 May 10. Ophthalmic Epidemiol. 2013. PMID: 23662986 Free PMC article. Clinical Trial.
-
Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis.JAMA Ophthalmol. 2013 Feb;131(2):147-53. doi: 10.1001/jamaophthalmol.2013.778. JAMA Ophthalmol. 2013. PMID: 23411878 Free PMC article.
-
Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.Cornea. 2011 Jan;30(1):83-90. doi: 10.1097/ICO.0b013e3181e2f0f3. Cornea. 2011. PMID: 20847656
-
Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.Cornea. 2015 Jun;34(6):698-703. doi: 10.1097/ICO.0000000000000431. Cornea. 2015. PMID: 25811722 Free PMC article. Review.
-
Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review.Crit Care. 2014 Dec 13;18(6):668. doi: 10.1186/s13054-014-0668-9. Crit Care. 2014. PMID: 25672496 Free PMC article. Review.
Cited by
-
The Host-Pathogen Interplay: A Tale of Two Stories within the Cornea and Posterior Segment.Microorganisms. 2023 Aug 12;11(8):2074. doi: 10.3390/microorganisms11082074. Microorganisms. 2023. PMID: 37630634 Free PMC article. Review.
-
An Organ System-Based Synopsis of Pseudomonas aeruginosa Virulence.Virulence. 2021 Dec;12(1):1469-1507. doi: 10.1080/21505594.2021.1926408. Virulence. 2021. PMID: 34180343 Free PMC article. Review.
-
Antibiotic Resistance Characteristics of Pseudomonas aeruginosa Isolated from Keratitis in Australia and India.Antibiotics (Basel). 2020 Sep 14;9(9):600. doi: 10.3390/antibiotics9090600. Antibiotics (Basel). 2020. PMID: 32937932 Free PMC article.
-
Effect of Different Antibiotic Chemotherapies on Pseudomonas aeruginosa Infection In Vitro of Primary Human Corneal Fibroblast Cells.Front Microbiol. 2017 Aug 22;8:1614. doi: 10.3389/fmicb.2017.01614. eCollection 2017. Front Microbiol. 2017. PMID: 28878761 Free PMC article.
-
Pseudomonas aeruginosa Type III Secretory Toxin ExoU and Its Predicted Homologs.Toxins (Basel). 2016 Oct 26;8(11):307. doi: 10.3390/toxins8110307. Toxins (Basel). 2016. PMID: 27792159 Free PMC article. Review.
References
-
- Laspina F, Samudio M, Cibils D, Ta CN, Farina N, Sanabria R, Klauss V, Mino de Kaspar H. Epidemiological characteristics of microbiological results on patients with infectious corneal ulcers: a 13-year survey in Paraguay. Graefes Arch Clin Exp Ophthalmol. 2004;242(3):204–209. doi: 10.1007/s00417-003-0808-4. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical